from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2122c/hisE

LFCtreatmentdescriptionclass of inhibitor

0.689

Amikacinug/mL Amikacintranslation

1.062

Cap5-10ug/mL Capreomycintranslation

1.321

Rox10-50 ug/mL Roxithromycintranslation

-0.409

SM2-5 ug/mL Streptomycintranslation

1.280

Tet5-10 ug/mL Tetracyclinetranslation

0.166

Rif0.2-5ug/mL Rifampicintranscription

-0.028

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.956

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.174

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.793

CPZ10-50 ug/mL Chlorpromazinerespiration

0.150

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.122

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.142

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.747

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.684

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.288

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.062

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.268

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.004

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.292

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.160

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.701

Nigericin50 uM Nigericinrespiration

0.309

TRC10-150 ug/mL Triclosanrespiration

-0.790

TRZ10-25 ug/mL Thioridazinerespiration

4.651

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.394

menadione6-10 ug/mL Menadionerespiration

0.363

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.240

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.013

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.145

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.584

NRP_1Non-replicating persistence stage 1dosRassociated

-0.047

Amp0.2mg/mL AmpicillincellWall

-0.087

Cephalexin20-100 ug/mL CephalexincellWall

-0.557

Cerulenin0.32-5 ug/mL CerulenincellWall

0.018

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.002

EMB10-20 ug/mL EthambutolcellWall

-0.031

Eta12-40 ug/mL EthionamidecellWall

0.037

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.138

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.366

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.002

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.300

BZA0.12 mg/mL BenzamidearomaticAmides

0.597

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.488

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.183

H2O24 mM hydrogen peroxideDNAdamaging

0.033

Levo10 ug/mL LevofloxacinDNAdamaging

-0.138

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.270

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.047

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.159

UVUV-irradiationDNAdamaging

-0.863

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.568

Antimycin12.5-50 ug/mL Antimycin A?

-0.558

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.605

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.651

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.875

PA8240.2-2 ug/mL PA-824?

-0.355

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.325

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.503

Verapamil50 uM Verapamil?

-0.597

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.581

methoxatin10-20 ug/mL Methoxatin?